Akihito Suzuki - Concepedia

Author

Akihito Suzuki

Yamagata University ORCID

Also Known As

A Suzuki, A. Suzuki, AKIHITO SUZUKI, Akihito SUZUKI, Akihito Suzuki, Suzuki A

217

Publications

Citations

H-Index

108

Concepts

All Affiliations

Yamagata University Hirosaki University Hirosaki University Hospital Mitsubishi Group (Japan)

About

Akihito Suzuki is an author at Yamagata University specializing in medicine, social sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	35	1.1K
2	Health Sciences	2	2	60
3	Education	1	1	20
4	Engineering	1	1	11
5	Language Studies	1	1	69

Akihito Suzuki

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients Akihito Suzuki, Kazuo Mihara, Tsuyoshi Kondo, Pharmacogenetics PsychopathologySelective Dopamine AntagonistPsychopharmacologyTherapeutic ResponseNeuropsychiatry	2000	99
Association of the <i>Taq</i>I A Polymorphism of the Dopamine D<sub>2</sub> Receptor Gene With Predisposition to Neuroleptic Malignant Syndrome Akihito Suzuki, Tsuyoshi Kondo, K. Otani, American Journal of Psychiatry	2001	80
A three-factor model of the MADRS in major depressive disorder Akihito Suzuki, Toshiaki Aoshima, Takashi Fukasawa, Depression and Anxiety	2005	76
The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients Reiji Yoshimura, Taro Kishi, Akihito Suzuki, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychiatryDepressed Japanese PatientsDepressionSchizophreniaNeuropharmacology	2011	71
Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients Akihito Suzuki, Koichi Otani, Kazuo Mihara, Pharmacogenetics Translation StudiesReduced HaloperidolJapanese HistoryEast Asian StudiesCyp2d6 Genotype	1997	69
The –141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients Akihito Suzuki, Tsuyoshi Kondo, Kazuo Mihara, Pharmacogenetics	2001	67
Association Between Serum Uric Acid Levels/Hyperuricemia and Hypertension Among 85,286 Japanese Workers Hirohide Yokokawa, Hiroshi Fukuda, Akihito Suzuki, Journal of Clinical Hypertension	2015	66
Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes Shingo Ono, Kazuo Mihara, Akihito Suzuki, Psychopharmacology Cyp2d6 GenotypesPharmacologyPharmacogenomicsPharmacotherapySignificant Pharmacokinetic Interaction	2002	66
Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome Kazuo Mihara, Tsuyoshi Kondo, Akihito Suzuki, American Journal of Medical Genetics Part B Neuropsychiatric Genetics	2002	63
Effects of various factors on steady‐state plasma concentrations of risperidone and 9‐hydroxyrisperidone: lack of impact of MDR‐1 genotypes Norio Yasui‐Furukori, Kazuo Mihara, Takenori Takahata, British Journal of Clinical Pharmacology	2004	59

Page 1